Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.

This work describes the installation, use, and quality control (QC) of the alumina-based tungsten-188 ( 188 W)/rhenium-188 ( 188 Re) generators provided by the Oak Ridge National Laboratory (ORNL). In addition, methods used for concentration of the 188 Re-perrhenate bolus and preparation of 188 Re-labeled HDD (4-hexadecyl-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanethiol) for trans-arterial administration for therapy of nonresectable liver cancer also are described. The 188 W/ 188 Re generator has a long useful shelf-life of several months and is a convenient on-site 188 Re production system. 188 Re has excellent therapeutic and imaging properties (T 1/2 16.9 hours; E βmax 2.12 MeV; 155-keV gamma ray, 15%) and is cost effectively obtained on demand by saline elution of the generator. The clinical efficacy of a variety of 188 Re-labeled agents has been demonstrated for several therapeutic applications. Because of the favorable physical properties of 188 Re, several 188 Re-labeled agents are being developed and evaluated for the treatment of nonresectable/refractory liver cancer. 188 Re-labeled HDD has been the most widely studied of these agents for this application and has been introduced into clinical trials at a number of institutions. The trans-arterial administration of 188 Re-labeled agents for treatment of inoperable liver cancer requires use of high-level (1-2 Ci) 188 W/ 188 Re generators. The handling of such high levels of 188 Re imposes radiological precautions normally not encountered in a radiopharmacy and adequate care and ALARA (ie, "As Low As Reasonably Achievable") principles must be followed. The ORNL generator provides consistently high 188 Re yields (>75%) and low 188 W parent breakthrough ( −3 %) over an extended shelf-life of several months. However, the high elution volumes (20-40 mL for 1-2 Ci generators) can require concentration of the 188 Re bolus by postelution passage through silver cation chloride trapping columns used in the cost-effective tandem cation/anion column system. The silver column removes the high levels of chloride anion as insoluble AgCl, thus allowing subsequent specific trapping of the perrhenate anion on the small (QMA SeaPak) anion column. This method permits subsequent elution of 188 Re-perrhenate with a small volume of saline, providing a very high activity-concentration solution. Because the 188 Re-specific volume-activity concentration continually decreases with time, the tandem system is especially effective method for extending the useful generator shelf-life. Low elution flow rates ( 188 Re-HDD have been optimized and this agent can be obtained in high yield (80%).